| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $660.8M | +55.8% |
| Cost of Revenue | $428.2M | +38.8% |
| R&D Expense | $3.7M | +23.3% |
| SG&A Expense | $116.2M | +14.4% |
| Operating Income | $49.1M | +829.5% |
| Interest Expense | $2.4M | -55.9% |
| Pre-tax Income | $142.8M | +960.4% |
| Income Tax | $2.5M | -80.7% |
| Net Income | $140.3M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Accounts Receivable | $239.5M | +76.7% |
| Inventory | $271.2M | +39.4% |
| Current Assets | $641.4M | -10.9% |
| Total Assets | $1.20B | +16.5% |
| Current Liabilities | $162.7M | +38.2% |
| Long-term Debt | $25.4M | -37.3% |
| Total Liabilities | $239.3M | +62.9% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $93.4M | +1109.3% |
| Investing Cash Flow | $78.4M | +198.3% |
| Financing Cash Flow | -$103.1M | — |
| — |
| EPS (Basic) | $2.82 | — |
| EPS (Diluted) | $2.77 | — |
| Stockholders' Equity |
| $958.2M |
| +8.7% |